Artificial intelligence and breast screening: French Radiology Community position paper - 25/09/19
, C. Balleyguier c, L. Ceugnart d, P. Heid e, G. Lenczner f, A. Maire g, B. Séradour d, L. Verzaux e, P. Taourel cand
Conseil national professionnel de la radiologie et imagerie médicale (G4)
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Abstract |
The objective of this article was to evaluate the evidence currently available about the clinical value of artificial intelligence (AI) in breast imaging. Nine experts from the disciplines involved in breast disease management – including physicists and radiologists – convened a meeting on June 3, 2019 to discuss the evidence for the use of this technology in plenary and focused sessions. Prior to the meeting, the group performed a literature review on predefined topics. This paper presents the consensus reached by this working group on recommendations for the future use of AI in breast screening and related research topics.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Artificial intelligence, Breast cancer, Screening program, Digital breast tomosynthesis, Digital mammography
Abbreviations : AI, MG, MLO, CC, CAD, ANN, CNN, Synth2DMG, QC, DL, R2, FDA, DBT, AP-HP
Mappa
Vol 100 - N° 10
P. 553-566 - ottobre 2019 Ritorno al numero
Articolo precedente
- Breast tomosynthesis: What do we know and where do we stand?
- C. Mandoul, C. Verheyden, I. Millet, C. Orliac, E. Pages, I. Thomassin, P. Taourel
- Breast sonoelastography: Now and in the future
- B. Mesurolle, M. El Khoury, F. Chammings, M. Zhang, S. Sun
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.